Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bruker Corp (BRKR)

Bruker Corp (BRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,816,301
  • Shares Outstanding, K 151,941
  • Annual Sales, $ 3,437 M
  • Annual Income, $ -8,600 K
  • EBIT $ 165 M
  • EBITDA $ 385 M
  • 60-Month Beta 1.19
  • Price/Sales 1.71
  • Price/Cash Flow 11.48
  • Price/Book 2.38

Options Overview Details

View History
  • Implied Volatility 53.56% (+1.56%)
  • Historical Volatility 53.74%
  • IV Percentile 43%
  • IV Rank 30.70%
  • IV High 85.94% on 04/10/25
  • IV Low 39.21% on 06/16/25
  • Expected Move (DTE 25) 4.58 (11.97%)
  • Put/Call Vol Ratio 1.71
  • Today's Volume 179
  • Volume Avg (30-Day) 707
  • Put/Call OI Ratio 0.45
  • Today's Open Interest 16,996
  • Open Int (30-Day) 14,634
  • Expected Range 33.70 to 42.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.26
  • Number of Estimates 5
  • High Estimate 0.39
  • Low Estimate 0.21
  • Prior Year 0.47
  • Growth Rate Est. (year over year) -44.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.62 +7.47%
on 02/12/26
53.50 -28.45%
on 01/22/26
-11.56 (-23.19%)
since 01/20/26
3-Month
35.62 +7.47%
on 02/12/26
56.22 -31.91%
on 01/12/26
-5.56 (-12.68%)
since 11/20/25
52-Week
28.53 +34.17%
on 09/03/25
56.22 -31.91%
on 01/12/26
-14.64 (-27.66%)
since 02/20/25

Most Recent Stories

More News
The Top 5 Analyst Questions From Bruker’s Q4 Earnings Call

The Top 5 Analyst Questions From Bruker’s Q4 Earnings Call

BRKR : 38.28 (-1.24%)
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 That Underwhelm

1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 That Underwhelm

WW : 22.81 (+3.31%)
NTNX : 39.84 (-3.58%)
BRKR : 38.28 (-1.24%)
3 Profitable Stocks We Keep Off Our Radar

3 Profitable Stocks We Keep Off Our Radar

SF : 119.91 (+0.41%)
BRKR : 38.28 (-1.24%)
PLUS : 81.95 (-0.98%)
Why Bruker (BRKR) Stock Is Trading Lower Today

Why Bruker (BRKR) Stock Is Trading Lower Today

BRKR : 38.28 (-1.24%)
Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates

Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates

BRKR : 38.28 (-1.24%)
Bruker: Q4 Earnings Snapshot

Bruker: Q4 Earnings Snapshot

BRKR : 38.28 (-1.24%)
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

Q4-25 revenues of $977.2 million, flat year-over-year (yoy), down ~5% organically Q4-25 GAAP diluted earnings per share (EPS) of $0.10; non-GAAP diluted...

BRKR : 38.28 (-1.24%)
Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration

At SLAS2026 , Chemspeed Technologies , a leader in the automation and digitalization of R&D and QC laboratories, and SciY , a leader in scientific and laboratory...

BRKR : 38.28 (-1.24%)
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

New iNTApharma system enables rapid, native‑state size and concentration measurements with single‑particle sensitivity for viral, vesicle, and nanoscale bioparticle workflows

BRKR : 38.28 (-1.24%)
Bruker Announces Quarterly Preferred Stock Dividend

Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $3.9844 per share on the Company’s...

BRKRP : 305.21 (-0.48%)
BRKR : 38.28 (-1.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science...

See More

Key Turning Points

3rd Resistance Point 40.15
2nd Resistance Point 39.55
1st Resistance Point 38.91
Last Price 38.28
1st Support Level 37.67
2nd Support Level 37.07
3rd Support Level 36.43

See More

52-Week High 56.22
Fibonacci 61.8% 45.64
Fibonacci 50% 42.38
Fibonacci 38.2% 39.11
Last Price 38.28
52-Week Low 28.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar